GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 7,160 | 5,891 | 126,856 | 1,285 | 1,538 |
| Operating Income | -7,160 | -5,891 | -126,856 | -1,285 | -1,538 |
| Interest Expense | 2,931 | 135 | 3,769 | 1,178 | 3,520 |
| Pre-tax Income | -10,091 | -6,026 | -130,625 | -2,463 | -5,058 |
| Net Income Continuous | -10,091 | -6,026 | -130,625 | -2,463 | -5,058 |
| Net Income | $-10,091 | $-6,026 | $-130,625 | $-2,463 | $-5,058 |
| EPS Basic Total Ops | -102.14 | 15,857.69 | -4,162.33 | -2,625.07 | -13,462.44 |
| EPS Basic Continuous Ops | -102.83 | 15,862.29 | -4,162.22 | -2,626.08 | -13,464.87 |
| EPS Diluted Total Ops | -102.14 | 15,857.69 | -4,162.33 | -2,625.07 | -13,462.44 |
| EPS Diluted Continuous Ops | -102.83 | 15,862.29 | -4,162.22 | -2,626.08 | -13,464.87 |
| EBITDA(a) | $-4,087 | $-5,768 | $-123,440 | $-723 | $-723 |